Tech Company Financing Transactions
Biolinq Funding Round
RiverVest Venture Partners, Alpha Wave Ventures and Ascensia participated in a $100 million capital raise for Biolinq. The round closed on 11/4/2021.
Transaction Overview
Company Name
Announced On
11/4/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The money will be used to push Biolinq's first product -- a continuous glucose monitor -- through regulatory review and initial launch.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4535 Towne Centre Ct. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Biolinq is a digital health company developing a skin-applied, minimally-invasive electrochemical biosensor platform which analyzes biomarkers in the interstitial fluid to provide actionable health information.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jared Tangney
Chief Technical Officer
Joshua Windmiller
VP - Regulatory Affairs
Thomas Peyser
Browse more venture capital transactions:
Prev: 11/4/2021: Marker Learning venture capital transaction
Next: 11/4/2021: QuestDB venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs